Phibro Animal Health (PAHC) Equity Average (2014 - 2026)

Phibro Animal Health's Equity Average history runs 13 years deep, the most recent figure standing at $347.1 million for Q1 2026.

• In Q1 2026, Equity Average rose 35.37% year-over-year to $347.1 million; the TTM figure through Mar 2026 stood at $347.1 million (up 35.37% YoY), while the FY2025 annual figure was $271.2 million, up 0.59% from the prior year.
• Equity Average was $347.1 million for Q1 2026 at Phibro Animal Health, up from $322.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $347.1 million in Q1 2026 to a low of $252.7 million in Q4 2024.
• Historically, Equity Average has averaged $275.7 million across 5 years, with a median of $270.3 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Equity Average slipped 7.27% in 2024, then jumped 35.37% in 2026.
• A 5-year view of Equity Average shows it stood at $265.6 million in 2022, then increased by 2.4% to $271.9 million in 2023, then fell by 7.09% to $252.7 million in 2024, then increased by 27.45% to $322.0 million in 2025, then grew by 7.79% to $347.1 million in 2026.
• The last three Equity Average figures came in at $347.1 million (Q1 2026), $322.0 million (Q4 2025), and $298.7 million (Q3 2025), per Business Quant data.